Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03480646
Title ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Constellation Pharmaceuticals
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Abiraterone + CPI-1205 + Prednisone

CPI-1205 + Enzalutamide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.